Browse the corpus

Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.

1 passage

abstractpubmed· Abstract· item 41569669

The role of surveillance MRI scans in patients with sporadic cerebral cavernous malformations. OBJECTIVE: This study evaluated the utility of routine versus symptom-driven MRI to detect hemorrhage in patients with sporadic cerebral cavernous malformations (CCMs) and assessed associated radiographic changes at the first clinical follow-up. METHODS: The authors analyzed a prospective, single-center cohort of patients with sporadic, brain-only CCMs who underwent at least 1 follow-up MRI after diagnosis. Clinical and radiological data were obtained from a longitudinal registry. Follow-up findings included lesion growth (≥ 3 mm), changes in Zabramski classification, persistent T1-weighted hyperintensity, edema, and hemorrhage. MRI indications were categorized as routine surveillance or symptom driven (e.g., new or worsening focal neurological deficit [FND], headache, or seizure). Univariate and multivariate analyses were performed to assess predictors of symptomatic hemmorhage (SH). RESULTS: Of 236 included patients, 59.3% were female, and 39.8% initially presented with SH. At the first follow-up MRI, radiographic hemorrhage was observed in 13 of 68 patients (19.1%) imaged for new or worsening neurological symptoms (FND, headaches, or seizures), compared to 2 of 168 patients (1.2%) during routine or non-CCM-related surveillance. Among these 168 patients, 17 (10.1%) showed radiological progression-including lesion growth (n = 11 [6.5%]), a change to a more aggressive Zabramski type (n = 10 [6.0%]), and radiological evidence of acute hemorrhage (n = 2 [1.2%]). Most of these events (88.2%) occurred within 2 years. SH was characterized by lesion growth, moderate-to-severe T1-hyperintensity, and edema. Baseline lesion size and location did not predict hemorrhage. New or worsening FND predicted hemorrhage, whereas seizure and headache alone did not. In the multivariate analysis, only the presence of new or worsening FND remained independently associated with hemorrhage (OR 13.73, p < 0.001). CONCLUSIONS: In patients with known CCM, MRI should be performed in case of new or worsening FND, as this was the strongest predictor of hemorrhage. Routine surveillance had limited diagnostic yield in asymptomatic patients but may be appropriate in select cases.